Élisabeth Éléfant

4.2k total citations · 1 hit paper
87 papers, 2.2k citations indexed

About

Élisabeth Éléfant is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Élisabeth Éléfant has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Public Health, Environmental and Occupational Health, 33 papers in Pediatrics, Perinatology and Child Health and 11 papers in Surgery. Recurrent topics in Élisabeth Éléfant's work include Pregnancy and Medication Impact (37 papers), Pregnancy and preeclampsia studies (9 papers) and Reproductive System and Pregnancy (9 papers). Élisabeth Éléfant is often cited by papers focused on Pregnancy and Medication Impact (37 papers), Pregnancy and preeclampsia studies (9 papers) and Reproductive System and Pregnancy (9 papers). Élisabeth Éléfant collaborates with scholars based in France, United States and Germany. Élisabeth Éléfant's co-authors include Thierry Vial, Maria Hoeltzenbein, Delphine Beghin, Frauke Förger, Christina Chambers, Irene Cetin, Munther A. Khamashta, Carina Gøtestam Skorpen, Guillermo Ruiz‐Irastorza and A. Zink and has published in prestigious journals such as PLoS ONE, Neurology and Cancer.

In The Last Decade

Élisabeth Éléfant

79 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

2016 689 citations Maria Hoeltzenbein, Élisabeth Éléfant et al. profile →

Peers

Countries citing papers authored by Élisabeth Éléfant

Since Specialization

Citations

This map shows the geographic impact of Élisabeth Éléfant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élisabeth Éléfant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élisabeth Éléfant more than expected).

Fields of papers citing papers by Élisabeth Éléfant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élisabeth Éléfant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élisabeth Éléfant. The network helps show where Élisabeth Éléfant may publish in the future.

Co-authorship network of co-authors of Élisabeth Éléfant

This figure shows the co-authorship network connecting the top 25 collaborators of Élisabeth Éléfant. A scholar is included among the top collaborators of Élisabeth Éléfant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Élisabeth Éléfant. Élisabeth Éléfant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service 2025 ·Lara D. Veeken ·Valentine Faure‐Bardon, Delphine Beghin, Bruno Fautrel, (unknown), Catherine Vauzelle, (unknown), Élisabeth Éléfant, Bénédicte Coulm, Benôıt Marin	0
2	La nouvelle version du site internet du Centre de référence sur les agents tératogènes et ses fonctionnalités optimisées 2024 ·Gynécologie Obstétrique Fertilité & Sénologie ·Bénédicte Coulm, Delphine Beghin, (unknown), Bilal Majed, Catherine Vauzelle, Élisabeth Éléfant, Benôıt Marin	1
3	Post-Conceptional Exposure to Clomiphene Citrate and Congenital Malformations: A Cohort Study 2024 ·Drug Safety ·(unknown), Catherine Vauzelle, Delphine Beghin, (unknown), Élisabeth Éléfant, Bénédicte Coulm, Benôıt Marin	0
4	Neonatal outcomes after in utero exposure to antipsychotics: a systematic review and meta-analysis 2024 ·European Journal of Epidemiology ·(unknown), (unknown), Agnès Dechartres, Hedvig Nordeng, Jonathan L. Richardson, Élisabeth Éléfant, Delphine Mitanchez, Benôıt Marin	4
5	Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection 2020 ·PLoS ONE ·Valentine Faure‐Bardon, Gilles Peytavin, Minh Lê, Tiffany Guilleminot, Élisabeth Éléfant, J. Stirnemann, Marianne Leruez‐Ville, Y. Ville	15
6	Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease 2017 ·A&A Practice ·Rémi Favier, (unknown), Élisabeth Éléfant, (unknown), (unknown), (unknown)	20
7	Continuation of pregnancy after first‐trimester exposure to mifepristone: an observational prospective study 2013 ·BJOG An International Journal of Obstetrics & Gynaecology ·Nathalie Bernard, Élisabeth Éléfant, P. Carlier, (unknown), (unknown), (unknown), Emmanuelle Amar, J Descotes, Thierry Vial	27
8	Pharmacovigilance : actualités et perspectives 2012 ·Bulletin de l Académie Nationale de Médecine ·Jean‐Louis Montastruc, (unknown), Jean‐Paul Tillement, D Bontoux, Jean–Paul Bounhoure, G Bouvenot, Catherine Buffet, (unknown), Élisabeth Éléfant, Jean‐Paul Giroud, Régis Gonthier, Jean‐Pierre Goullé, Patrice Jaillon, Pierre Joly, Y Juillet, Michel Lhermitte, Charles-Joël Menkès, (unknown), Patrice Queneau, (unknown), R Trèves, J. Doucet	3
9	Le passage placentaire des immunoglobulines 2012 ·Bulletin de l Académie Nationale de Médecine ·Élisabeth Éléfant	5
10	Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services 2012 ·American Journal of Medical Genetics Part A ·Maria Hoeltzenbein, Élisabeth Éléfant, Thierry Vial, (unknown), Sally Stephens, Maurizio Clementi, Arthur Allignol, Corinna Weber‐Schoendorfer, Christof Schaefer	139
11	Paternal Exposure to Methotrexate and Pregnancy Outcomes 2011 ·The Journal of Rheumatology ·Delphine Beghin, Maxime Cournot, Catherine Vauzelle, Élisabeth Éléfant	40
12	Isotretinoin Exposure during Pregnancy 2010 ·Drug Safety ·E. Autret‐Leca, C. Kreft-Jaïs, Élisabeth Éléfant, (unknown), (unknown), Lamiae Grimaldi‐Bensouda, (unknown), A.‐P. Jonville‐Béra	20
13	Immunosuppresseurs utilisés dans les maladies systémiques : que faire en cas de grossesse ? 2008 ·La Presse Médicale ·Élisabeth Éléfant, Maxime Cournot, (unknown), Catherine Vauzelle	5
14	Isotrétinoïne : suivi de l’application des recommandations des prescriptions chez les femmes en âge de procréer 2005 ·Annales de Dermatologie et de Vénéréologie ·(unknown), (unknown), (unknown), Élisabeth Éléfant, (unknown), C. Delmas, (unknown), Pierre Coste, E. Autret‐Leca	9
15	Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. 2004 ·PubMed ·(unknown), Thierry Vial, Élisabeth Éléfant, Agnès Nelva, P. Carlier, Jacques Descotes	71
16	[Teratogenesis and medication induced fetal toxicity]. 2003 ·PubMed ·Élisabeth Éléfant, F Bavoux	1
17	Grossesse et médicaments 2001 ·F Bavoux, Élisabeth Éléfant, Elisabeth Rey, Gérard Pons	2
18	Toxicologie de la reproduction: valeurs prédictives des modèles expérimentaux. Table Ronde No 1 de Giens XIII. 1998 ·Therapies ·(unknown), (unknown), E Autret, (unknown), Élisabeth Éléfant, Évelyne Jacqz-Aigrain, Jérémy Bigot, (unknown), Daniel Marzin, Marc Pallardy, (unknown), (unknown), Géraldine Lo Siou, Jean-Claude Soufir, (unknown), (unknown)	1
19	Cholesterol Prevents the Teratogenic Action of AY 9944: Importance of the Timing of Cholesterol Supplementation to Rats 1988 ·Journal of Nutrition ·Véronique Barbu, Charles Roux, (unknown), R Dupuis, J. Gardette, (unknown), Cécile Mazière, Élisabeth Éléfant, J. Polonovski	44
20	Urolithiasis in infants. 1962 ·Élisabeth Éléfant, Marina Brodsky, J Jelínek	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact